Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Chemotherapy-Induced Nausea and Vomiting Drugs Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview:
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Chemotherapy-Induced Nausea and Vomiting Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Chemotherapy-Induced Nausea and Vomiting Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Chemotherapy-Induced Nausea and Vomiting Drugs market in 2020.
Global Chemotherapy-Induced Nausea and Vomiting Drugs Market Segmentation
By Type, Chemotherapy-Induced Nausea and Vomiting Drugs market has been segmented into:
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant
By Application, Chemotherapy-Induced Nausea and Vomiting Drugs market has been segmented into:
Serotonin Receptor Antagonists
NK1 Receptor Antagonists
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Chemotherapy-Induced Nausea and Vomiting Drugs market are:
Merck & Co. Inc.
GlaxoSmithKline plc
Tesaro Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co. Ltd.
1. Market Overview of Chemotherapy-Induced Nausea and Vomiting Drugs
1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Market Overview
1.1.1 Chemotherapy-Induced Nausea and Vomiting Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Size by Regions (2015-2020)
1.4 Chemotherapy-Induced Nausea and Vomiting Drugs Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market by Type (2015-2026)
2.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Size by Type (2015-2020)
2.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecasted Market Size by Type (2021-2026)
2.3 Existing Drugs
2.4 Akynzeo (Netupitant-Palonosetron FDC)
2.5 Aloxi (Palonosetron)
2.6 Emend (Aprepitant)
2.7 Kytril Generic (Granisetron)
2.8 Zofran Generic (Ondansetron)
2.9 Pipeline Drugs
2.10 SUSTOL (Granisetron Injection extended release)
2.11 Rolapitant
3. Covid-19 Impact Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market by Application (2015-2026)
3.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Historic Market Size by Application (2015-2020)
3.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Forecasted Market Size by Application (2021-2026)
3.3 Serotonin Receptor Antagonists
3.4 NK1 Receptor Antagonists
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Chemotherapy-Induced Nausea and Vomiting Drugs Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Chemotherapy-Induced Nausea and Vomiting Drugs Business
5.1 Merck & Co. Inc.
5.1.1 Merck & Co. Inc. Company Profile
5.1.2 Merck & Co. Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Specification
5.1.3 Merck & Co. Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 GlaxoSmithKline plc
5.2.1 GlaxoSmithKline plc Company Profile
5.2.2 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Product Specification
5.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Tesaro Inc.
5.3.1 Tesaro Inc. Company Profile
5.3.2 Tesaro Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Specification
5.3.3 Tesaro Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Helsinn Group
5.4.1 Helsinn Group Company Profile
5.4.2 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Product Specification
5.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 F. Hoffmann-La Roche Ltd.
5.5.1 F. Hoffmann-La Roche Ltd. Company Profile
5.5.2 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Specification
5.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Heron Therapeutics Inc.
5.6.1 Heron Therapeutics Inc. Company Profile
5.6.2 Heron Therapeutics Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Product Specification
5.6.3 Heron Therapeutics Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Dr. Reddy's Laboratories Ltd.
5.7.1 Dr. Reddy's Laboratories Ltd. Company Profile
5.7.2 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Specification
5.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Acacia Pharma
5.8.1 Acacia Pharma Company Profile
5.8.2 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Product Specification
5.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Sun Pharmaceutical Industry Ltd.
5.9.1 Sun Pharmaceutical Industry Ltd. Company Profile
5.9.2 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Specification
5.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Otsuka Holdings Co. Ltd.
5.10.1 Otsuka Holdings Co. Ltd. Company Profile
5.10.2 Otsuka Holdings Co. Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Product Specification
5.10.3 Otsuka Holdings Co. Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (2015-2026)
6.2 North America Chemotherapy-Induced Nausea and Vomiting Drugs Key Players in North America (2015-2020)
6.3 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type (2015-2020)
6.4 North America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (2015-2026)
7.2 East Asia Chemotherapy-Induced Nausea and Vomiting Drugs Key Players in North America (2015-2020)
7.3 East Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type (2015-2020)
7.4 East Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application (2015-2020)
8. Europe
8.1 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (2015-2026)
8.2 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Key Players in North America (2015-2020)
8.3 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type (2015-2020)
8.4 Europe Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (2015-2026)
9.2 South Asia Chemotherapy-Induced Nausea and Vomiting Drugs Key Players in North America (2015-2020)
9.3 South Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type (2015-2020)
9.4 South Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (2015-2026)
10.2 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Key Players in North America (2015-2020)
10.3 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (2015-2026)
11.2 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Key Players in North America (2015-2020)
11.3 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type (2015-2020)
11.4 Middle East Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application (2015-2020)
12. Africa
12.1 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (2015-2026)
12.2 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Key Players in North America (2015-2020)
12.3 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type (2015-2020)
12.4 Africa Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (2015-2026)
13.2 Oceania Chemotherapy-Induced Nausea and Vomiting Drugs Key Players in North America (2015-2020)
13.3 Oceania Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type (2015-2020)
13.4 Oceania Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application (2015-2020)
14. South America
14.1 South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (2015-2026)
14.2 South America Chemotherapy-Induced Nausea and Vomiting Drugs Key Players in North America (2015-2020)
14.3 South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type (2015-2020)
14.4 South America Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (2015-2026)
15.2 Rest of the World Chemotherapy-Induced Nausea and Vomiting Drugs Key Players in North America (2015-2020)
15.3 Rest of the World Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Type (2015-2020)
15.4 Rest of the World Chemotherapy-Induced Nausea and Vomiting Drugs Market Size by Application (2015-2020)
16 Chemotherapy-Induced Nausea and Vomiting Drugs Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Chemotherapy Induced Nausea and Vomiting Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|